Clinical Pharmacology Subcommittee
Of the
Advisory Committee for Pharmaceutical Science

November 14-15, 2005

Briefing Information

FDA

Disclaimer

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. 552).
These redacted portions will appear as white space on the screen or on the printed page.

FDA Backgrounder Table of Contents